SCHEMBL6281573

SCHEMBL6281573

C[C@H](O)[C@H](C)n1ncc2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.40
RECQL P46063 1/20 0.39
KMO O15229 2/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
CYP1A2 P05177 1/20 0.36
ASAH1 Q13510 1/20 0.35
HDAC8 Q9BY41 4/20 0.34
LMNA P02545 2/20 0.34
SLC22A12 Q96S37 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20622947 0.85 RECQL (0.41) ELANERECQLKMOMEN1KMT2A
SCHEMBL29350890 0.81 RECQL (0.43) ELANERECQLKMOMEN1KMT2A
SCHEMBL878425 0.81 RECQL (0.43) ELANERECQLKMOMEN1KMT2A
SCHEMBL29311539 0.78 RECQL (0.41) ELANERECQLKMOMEN1KMT2A
SCHEMBL21276545 0.78 RECQL (0.41) ELANERECQLKMOMEN1KMT2A
SCHEMBL18135251 0.78 ELANE (0.41) ELANERECQLKMOMEN1KMT2A
SCHEMBL31326725 0.78 KMO (0.42) ELANERECQLKMOMEN1KMT2A
SCHEMBL18135255 0.78 KMO (0.42) ELANERECQLKMOMEN1KMT2A
SCHEMBL6176042 0.77 KMO (0.43) ELANERECQLKMOMEN1KMT2A
Oxalic Acid SCHEMBL14810479 0.76 KMO (0.46) ELANERECQLKMOMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6875765-B2 Arylsulfonamide ethers, and methods of use thereof WARNER-LAMBERT COMPANY (US) 2005-04-05 US disclosed
US-20030096826-A1 Arylsulfonamide ethers, and methods of use thereof WARNER-LAMBERT COMPANY 2003-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096826-A1 Arylsulfonamide ethers, and methods of use thereof CASP1, IRAK1, STS ELANE 27/4885RECQL 2311/4885KMO 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.